-
201
Molecular Insights in the Anticancer Activity of Natural Tocotrienols: Targeting Mitochondrial Metabolism and Cellular Redox Homeostasis
Published 2025-01-01“…Cancer cells maintain moderate levels of ROS to promote tumorigenesis, metastasis, and drug resistance; indeed, once the cytotoxicity threshold is exceeded, ROS trigger oxidative damage, ultimately leading to cell death. …”
Get full text
Article -
202
Steroid hormone-induced wingless ligands tune female intestinal size in Drosophila
Published 2025-01-01“…Together, our findings provide insights into the complex endocrine growth control mechanisms during mating-induced adaptations and might help untangling pleiotropic hormonal effects observed in gastrointestinal tumorigenesis.…”
Get full text
Article -
203
Pan-Cancer Analysis of the Cuproptosis-Related Gene DLD
Published 2023-01-01“…DLD expression is associated with a variety of tumor prognoses and plays an integral role in tumorigenesis, tumor metabolism, and immunity.…”
Get full text
Article -
204
Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available cl...
Published 2023-07-01“…It is essential to develop drugs against novel targets––involved in CRC tumorigenesis and progression––to improve the management of the disease. …”
Get full text
Article -
205
Inhibitory Effect of Aconitine on Colorectal Cancer Malignancy via Inducing Apoptosis and Suppression of Cell Motion
Published 2025-01-01“…Animal experiments were performed to further elucidate aconitine’s effect on CRC tumorigenesis. Results: Aconitine time- and dose-dependently restrained CRC cell viability but was not cytotoxic to normal colorectal mucosa cells. …”
Get full text
Article -
206
Research Progress of SGLT2 Inhibitors in Cancer Treatment
Published 2025-01-01“…This article provides a comprehensive review of the role of SGLT2 in tumorigenesis and tumor progression, and explores the underlying mechanisms and potential therapeutic applications of SGLT2 inhibitors as anticancer agents.Keywords: SGLT2 inhibitors, SGLT2, cancer, mechanism…”
Get full text
Article -
207
The Beneficial Effects of GLP-1 Receptor Agonists Other than Their Anti-Diabetic and Anti-Obesity Properties
Published 2024-12-01“…In recent years, different beneficial effects of GLP-1R agonists were discovered, such as reducing ischemia-reperfusion injury, improving the function of various organs, alleviating substance use disorder, affecting tumorigenesis, regulating bone metabolism, changing gut microbiota composition, and prolonging graft survival. …”
Get full text
Article -
208
The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer
Published 2022-01-01“…Therefore, this study is aimed at investigating whether FGFR3 is promising as a biomarker of TME remodeling to explain underlying mechanisms involved in tumorigenesis and metastasis, which may help to make decisions on treatments for bladder cancer.…”
Get full text
Article -
209
A Novel Ferroptosis-Related Gene Signature for Prognosis Prediction in Ewing Sarcoma
Published 2022-01-01“…Ferroptosis, as a form of programmed cell death independent of apoptosis, has been demonstrated that plays a major role in tumorigenesis and cancer treatment. A comprehensive analysis of ferroptosis-related genes (FRGs) may lead to a novel choice for the treatment of Ewing sarcoma (ES). …”
Get full text
Article -
210
Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
Published 2023-07-01“…EGFR is known to act as a driver of tumorigenesis in various carcinomas. Over expression of EGFR in HNSCC is associated with poor prognosis and resistance to radiotherapy. …”
Get full text
Article -
211
Balancing Inflammation: The Link between Th17 and Regulatory T Cells
Published 2016-01-01“…The balance between these two cell populations is essential for immune homeostasis and dysregulation of this balance has been implicated in a variety of inflammatory conditions including autoimmunity, allograft rejection, and tumorigenesis. Emerging evidence reports a significant amount of plasticity between the Th17 and regulatory T cell compartments, and the mechanisms by which these cells communicate and influence each other are just beginning to be understood. …”
Get full text
Article -
212
PPAR Agonists for the Prevention and Treatment of Lung Cancer
Published 2017-01-01“…PPARα activation generally inhibits tumorigenesis through its antiangiogenic and anti-inflammatory effects. …”
Get full text
Article -
213
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
Published 2025-01-01“…The carcinogenic activities of SBAs include DNA damage, promotion of oxidative stress, and modulation of signaling pathways that drive tumorigenesis. Conversely, some SBAs exhibit anticancer properties by inducing apoptosis, inhibiting cell proliferation, and modulating immune responses. …”
Get full text
Article -
214
Ligand-Based Pharmacophore Modeling and Virtual Screening of RAD9 Inhibitors
Published 2013-01-01“…Aberrant RAD9 expression has been linked to breast, lung, thyroid, skin, and prostate tumorigenesis. Overexpression of RAD9 interacts with BCL-2 proteins and blocks the binding sites of BCL-2 family proteins to interact with chemotherapeutic drugs and leads to drug resistance. …”
Get full text
Article -
215
Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA
Published 2022-01-01“…Long noncoding RNAs (lncRNAs) actively participate in breast cancer (BRCA) tumorigenesis via epigenetic mechanisms. Our study identified immune-related lncRNA (irlncRNA) pairs and compiled them into a set of noncoding gene signatures able to stratify subtypes of BRCA associated with variable degrees of survival and immune cell infiltration. …”
Get full text
Article -
216
Macrophages in Tumor Microenvironments and the Progression of Tumors
Published 2012-01-01“…This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.…”
Get full text
Article -
217
Targeting RNA splicing modulation: new perspectives for anticancer strategy?
Published 2025-01-01“…In this review, we summarize the splice-altered signatures of cancer cell transcriptomes and the contributions of splicing aberrations to tumorigenesis and progression. Especially, we discuss current and emerging RNA splicing-targeted strategies for cancer therapy, including pharmacological approaches and splice-switching antisense oligonucleotides (ASOs). …”
Get full text
Article -
218
Identification of ferroptosis-related signature predicting prognosis and therapeutic responses in pancreatic cancer
Published 2025-01-01“…Abstract Ferroptosis plays a role in tumorigenesis by affecting lipid peroxidation and metabolic pathways; however, its prognostic or therapeutic relevance in pancreatic adenocarcinoma (PAAD) remains poorly understood. …”
Get full text
Article -
219
lncRNA ZFAS1 Promotes HMGCR mRNA Stabilization via Binding U2AF2 to Modulate Pancreatic Carcinoma Lipometabolism
Published 2022-01-01“…Being one of the most lethal malignant tumors worldwide, pancreatic carcinoma (PC) shows strong invasiveness and high mortality. In tumorigenesis and progression, the role played by long-chain noncoding RNAs (lncRNAs) cannot be ignored. …”
Get full text
Article -
220
Prognostic and clinicopathological significance of mucin family members expression in gastric cancer: a meta-analysis
Published 2025-01-01“…Several important mucins exert the function of tumorigenesis or progression in gastric cancer (GC). …”
Get full text
Article